RxDoctor Payments Data

Soham Roy

Pediatric Otolaryngology · Aurora, CONPI 1649295494

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (40.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Novartis at 34.6% of the total. Among pediatric otolaryngology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$33,653in general payments, 2019–2025

Across 75 payments — averaging $448.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$12K
  • Smiths Medical ASD, Inc.$7K
  • ICU Medical Inc$7K
  • Smith+Nephew$2K
  • Sanofi$2K
  • Medtronic$924
  • plus $3K from 16 others

What the payments were for

  • Royalty or licence$1,2004%
  • Consulting fees$13,57040%
  • Speaking & faculty fees$10,27031%
  • Travel & lodging$3,86711%
  • Food & beverage$4,47413%
  • Entertainment$2721%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,653 in reported general payments places this provider in the 95th percentile of 22 pediatric otolaryngology providers in Colorado.

See all pediatric otolaryngology providers in Colorado

Other pediatric otolaryngology in Aurora

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →